Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial
- DOI
- 10.1186/s12882-026-05153-z
- Published
- 2026-06-29
- Container
- BMC Nephrology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12882-026-05153-z,
title = {Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial},
author = {Kosuke Osawa and Shin-ichi Araki and Yusuke Tanaka and Masaki Ohya and Toshihiro Kodama and Yasushi Saika and Shigeo Negi and Shuto Yamamoto and Tsunehisa Matsuo and Yoji Ogawa and Norifumi Katayama and Yusuke Shigi and Tomomi Naito and Toshio Shimokawa and Takashi Shigematsu},
year = {2026},
journal = {BMC Nephrology},
doi = {10.1186/s12882-026-05153-z},
url = {https://doi.org/10.1186/s12882-026-05153-z}
}RIS
TY - JOUR TI - Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial AU - Kosuke Osawa AU - Shin-ichi Araki AU - Yusuke Tanaka AU - Masaki Ohya AU - Toshihiro Kodama AU - Yasushi Saika AU - Shigeo Negi AU - Shuto Yamamoto AU - Tsunehisa Matsuo AU - Yoji Ogawa AU - Norifumi Katayama AU - Yusuke Shigi AU - Tomomi Naito AU - Toshio Shimokawa AU - Takashi Shigematsu PY - 2026 JO - BMC Nephrology DO - 10.1186/s12882-026-05153-z UR - https://doi.org/10.1186/s12882-026-05153-z ER -
APA
Osawa, K., Araki, S., Tanaka, Y., Ohya, M., Kodama, T., Saika, Y., Negi, S., Yamamoto, S., Matsuo, T., Ogawa, Y., Katayama, N., Shigi, Y., Naito, T., Shimokawa, T., & Shigematsu, T. (2026). Efficacy and safety of single high-dose intravenous ferric carboxymaltose in patients undergoing hemodialysis: a multicenter, single-arm, open-label, clinical trial. BMC Nephrology. https://doi.org/10.1186/s12882-026-05153-z
Source records
- crossref · retrieved 2026-09-27T12:00:37.375Z